Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Applications of Integration to Probability Density Functions01:27

Applications of Integration to Probability Density Functions

Continuous probability distributions are used to model random variables that can take on any real value within a specified range. These variables do not take on isolated or countable values but rather exist on a continuum. For example, the height of an individual can be measured with increasing precision—such as 163.5 or 165.25 centimeters—demonstrating that height is a continuous random variable.The behavior of such variables is described using a probability density function (PDF), which...
Distributions to Estimate Population Parameter01:26

Distributions to Estimate Population Parameter

The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Probability Distributions01:32

Probability Distributions

The probability of a random variable x  is the likelihood of its occurrence. A probability distribution represents the probabilities of a random variable using a formula, graph, or table. There are two types of probability distribution– discrete probability distribution and continuous probability distribution.
A discrete probability distribution is a probability distribution of discrete random variables. It can be categorized into binomial probability distribution and Poisson probability...
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A historical note: Rediscovering an unpublished response to Korn and Freidlin (2011).

Statistical methods in medical research·2026
Same author

Efficient randomized adaptive designs for multi-arm clinical trials.

Statistical methods in medical research·2025
Same author

Statistical inference on the relative risk following covariate-adaptive randomization.

Biometrics·2025
Same author

Response-Adaptive Randomization Procedure in Clinical Trials with Surrogate Endpoints.

Statistics in medicine·2024
Same author

Group Response-Adaptive Randomization With Delayed and Missing Responses.

Statistics in medicine·2024
Same author

Robustness of response-adaptive randomization.

Biometrics·2024
Same journal

Are older adult research participants representative of the general population? Results from 19 clinical studies at one academic research center.

Contemporary clinical trials·2026
Same journal

Multi-site feasibility of a web-based and telephone navigation intervention to connect lung cancer caregivers in community oncology settings with resources: Protocol for the WF-2301CD caregiver oncology needs evaluation tool (CONNECT) trial.

Contemporary clinical trials·2026
Same journal

Rationale and design of a CArdiac rehabilitation program on the prevention of CardioTOXicity in breast Cancer patients undergoing treatment with anthracyclines and/or trastuzumab (CARPTOX-BC) trial: A randomized, active control group, open-label trial.

Contemporary clinical trials·2026
Same journal

Evaluating clinical outcomes of using Undermyfork mobile app with Dexcom G7: Protocol for CGM-Undermyfork randomized controlled trial.

Contemporary clinical trials·2026
Same journal

Outcomes of dyadic recruitment in the promoting re-engagement in meaningful activity (PRIMA) trial.

Contemporary clinical trials·2026
Same journal

Overview of the linking exercise for advancing daily stress (LEADS) management and resilience randomized controlled trial in African American families.

Contemporary clinical trials·2026
See all related articles

Related Experiment Video

Updated: May 15, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Balancing continuous covariates based on Kernel densities.

Zhenjun Ma1, Feifang Hu

  • 1Department of Statistics, University of Virginia, 22904 Charlottesville, USA.

Contemporary Clinical Trials
|December 29, 2012
PubMed
Summary
This summary is machine-generated.

Balancing continuous covariates in clinical trials is crucial. A new Kernel-Minimization method ensures distributional balance for all covariate types, improving randomization and avoiding issues seen in past trials.

Related Experiment Videos

Last Updated: May 15, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Randomization Techniques

Background:

  • Ensuring balance in baseline covariates is critical for valid treatment comparisons in clinical trials.
  • Current methods like stratified permuted block design and minimization require discrete covariates, often necessitating problematic discretization of continuous variables.
  • Discretizing continuous covariates can alter their nature and hinder distributional balance, impacting study validity.

Purpose of the Study:

  • To introduce a novel method, Kernel-Minimization, for balancing continuous covariates in clinical trial randomization.
  • To demonstrate the capability of Kernel-Minimization in achieving distributional balance for both continuous and categorical covariates.
  • To enhance the predictability and robustness of randomization schemes in clinical trials.

Main Methods:

  • Proposing Kernel-Minimization, a novel randomization strategy leveraging Kernel density estimations to maintain covariate continuity.
  • Conducting simulation studies to evaluate the performance of Kernel-Minimization against traditional methods.
  • Applying the Kernel-Minimization method to a real-world controversial trial (NINDS trial) for practical assessment.

Main Results:

  • Kernel-Minimization effectively achieves distributional balance for both continuous and categorical covariates.
  • The proposed method ensures well-balanced group sizes in simulations.
  • Kernel-Minimization demonstrates improved unpredictability compared to stratified permuted block design and minimization.
  • Simulations indicate that Kernel-Minimization can prevent imbalances similar to those observed in the NINDS trial.

Conclusions:

  • Kernel-Minimization offers a superior approach to balancing continuous covariates in clinical trial randomization.
  • This method enhances the integrity of treatment comparisons by maintaining covariate distributions.
  • The successful application to the NINDS trial suggests broad utility for improving controversial trial designs.